Comparison of the effects of conjugated estrogen treatment on blood lipid and lipoprotein levels when initiated in the first or fifth postmenopausal year

Gynecological Endocrinology

Volumn 13, Issue 2, 1999, Pages 118-122

  Aygen, E M ^a,b   Karakucuk E I ^a   Basbug M ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Conjugated equine estrogen; Lipid profiles; Menopause

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STATISTICAL ANALYSIS;

EID: 0033055604     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599909167543     Document Type: Article

References (20)

1. 1. Griffin B, Farish E, Walsh D, et al. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause. Clin Endocrinol 1993;39:463-8
2. 2. Castelo-Branco C, Casals E, Sanllehy C, et al. Effect of oophorectomy and hormone replacement therapy on plasma lipids. Maturitas 1993;17:113-22
3. 3. Kritz-Silverstein D, Barrett-Connor E, Wingard DL. Hysterectomy, oophorectomy and heart disease risk factors in older women. Am J Public Health 1997;87:676-80
4. 4. Montgomery JC, Crook D, Godsland IFI, et al. Plasma lipid risk factors in oophorectomize woman. Br J Obstet Gynaecol 1989;96:1236-8
5. 5. Farish E, Fletcher CD, Hart DM, et al. Effect of bilateral oophorectomy on lipoprotein metabolism. Br J Obstet Gynaecol 1990;97:78-82
6. 6. Bruschi F, Meschia M, Soma M, et al. Lipoprotein (a) and other lipids after oophorectomy and estrogen replacement therapy. Obstet Gynecol 1996;88: 950-4
7. 7. Orth-Gomer K, Mittleman MA, Schenck-Gustafsson K, et al. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation 1997;95:329-34
8. 8. Pansini F, Bergamini C, Bettochi S, et al. Short term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest 1984;18:134-9
9. 9. Sonnendecker EWW, Polakow ES, Benade AJS, et al. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogenmedrogestone regimen in hysterectomized postmenopausal women. Am J Obstet Gynecol 1989; 160:1128-34
10. 10. Castelli WP. Epidemiology of coronary heart disease: The Framingham study. Am J Med 1984; 76:4-12
11. 11. Punnonen R, Rauramo L. The effect of castration and estrogen therapy on serum high-density lipoprotein cholesterol. Int J Gynaecol Obstet 1980; 17:434-6
12. 12. Notelovitz M, Johnston M, Smith S, et al. Metabolic and hormonal effect of 25-mg and 50-mg 17β-estradiol implants in surgically menopausal women. Obstet Gynecol 1987;70:749-54
13. 13. Hennekens CH. Hormone replacement therapy: current perspectives and future directions. Eur Heart J 1997;18:1362-3
14. 14. Wild RA, Taylor EL, Knehans A. The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol 1995;172:1-13
15. 15. Brush TL, Miller VT. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In Mishell DR, eds. Menopause: Physiology and Pharmacology. Chicago: Year Book Medical, 1987:187-208
16. 16. Erenus M, Kutlay K, Kutlay L. Comparasion of the impact of oral versus transdermal estrogen on serum lipids. Fertil Steril 1994;61:300-2
17. 17. Walsh BW, Schiff, I, Rosner B. Effect of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:196-204
18. 18. Weinstein L. Hormonal therapy in the patient with surgical menopause. Obstet Gynecol 1990; 75: 47s-50s
19. 19. Lindsay R. The menopause: sex steroids and osteoporosis. Clin Obstet Gynecol 1987;30:847-9
20. 20. Thorneycroft IH. The role of estrogen replacement therapy in the prevention of osteoporosis. Am J Obstet Gynecol 1989;160:1306-10